CommentPrecision medicine in COPD exacerbations
References (15)
- et al.
Systemic cytokines, clinical and physiological changes in patients hospitalized for exacerbation of COPD
Chest
(2007) - et al.
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary
Am J Respir Crit Care Med
(2017) - et al.
Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based study
Thorax
(2014) - et al.
Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD
Eur Respir J
(2013) - et al.
Different dyspnoea perception in COPD patients with frequent and infrequent exacerbations
Thorax
(2017) - et al.
Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers
Am J Respir Crit Care Med
(2011) - et al.
Precision medicine—personalized, problematic, and promising
N Engl J Med
(2015)
Cited by (22)
[Translated article] ANTES Program: One Year on
2022, Archivos de BronconeumologiaANTES Program: One Year on
2022, Archivos de BronconeumologiaHigh flow nasal therapy in Acute Exacerbation of COPD: Ready for the prime time?
2021, American Journal of Emergency MedicineGoals of COPD treatment: Focus on symptoms and exacerbations
2020, Respiratory MedicineCitation Excerpt :Pulmonary inflammation varies greatly between individuals, and this has proven challenging in terms of biomarker evaluation or inflammation-targeted therapeutic intervention [56]. Unlike COPD exacerbations [57], other acute presentations of chronic diseases (e.g. myocardial infarction) have specific and sensitive diagnostic toolkits, such as biomarkers and imaging techniques, that are used in routine management of patients [56]. Exacerbations can also be difficult to recognize, and many patients presenting with a COPD exacerbation have comorbid conditions, which complicates evaluation and management.
Biomarkers of DNA damage in COPD patients undergoing pulmonary rehabilitation: Integrating clinical parameters with genomic profiling
2019, Mutation Research - Genetic Toxicology and Environmental MutagenesisCitation Excerpt :The comprehensive understanding of the genomic profile is a critical step forward for the construction of a personalized therapeutic approach and will make the difference within the rehabilitative framework as a fundamental tool for the recovery of disability and the improvement of quality of life (QoL). The recent precision medicine approach, the so called ‘Rehabilomics’, represents a translational framework for programs of personalized rehabilitation, focused on linking personal biology to the bio-psychosocial constructs [32–36]. In this paper we will investigate in a group of COPD patients those variables that may predict the response to a program of pulmonary rehabilitation (PR), integrating clinical parameters with cellular and molecular measurements, offering the potential for more effective and individualized treatment options.
GOLD COPD DOCUMENT 2023: a brief update for practicing cardiologists
2024, Clinical Research in Cardiology